Skip to content

R&D at other companies

Merck & Co. logo
Merck & Co.MRK
$12.59B+248%
Amgen logo
AmgenAMGN
$1.72B+15.7%
MicroStrategy logo
MicroStrategyMSTR
$24.67M+1.0%
CNT
Canton Strategic Holdings, Inc. Common StockCNTN
$267.82K-54.9%
Ziff Davis logo
Ziff DavisZD
$13.64M-2.0%
Zscaler logo
ZscalerZS
$232.28M+36.8%

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-54.5%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Return on equity-108.2%-34.4pp
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Reported directly by CYPH in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's R&D?
CYPH (CYPH) reported R&D of $161K in Q1 2026.
How has CYPH's R&D changed year-over-year?
CYPH's R&D decreased by 98.8% year-over-year, from $12.91M to $161K.
What is the long-term trend for CYPH's R&D?
Over 3 years (2021 to 2025), CYPH's R&D has grown at a -7.2% compound annual growth rate (CAGR), from $32.16M to $25.67M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.